^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BNT116

    i
    Associations
    News

    Trials

    Company:
    BioNTech
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) (NCT05557591)
    Phase 2
    Regeneron Pharmaceuticals
    Recruiting
    Last update posted :
    02/10/2025
    Initiation :
    04/21/2023
    Primary completion :
    03/02/2027
    Completion :
    06/07/2027
    PD-L1
    |
    Libtayo (cemiplimab-rwlc) • BNT116